Glycolic Acid

Glycolic Acid

SCHEMBL224369

O=C([O-])CO.O=C([O-])CO.O=C([O-])CO.O=C([O-])CO.O=C([O-])CO.[NH4+].[Zr+4]

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CA4 P22748 6/20 0.47
OR51E2 Q9H255 1/20 0.41
CASP1 P29466 1/20 0.41
FFAR3 O14843 2/20 0.37
HDAC3 O15379 2/20 0.37
HDAC1 Q13547 2/20 0.37
HDAC2 Q92769 2/20 0.37
HDAC8 Q9BY41 2/20 0.37
CA1 P00915 2/20 0.33
CA2 P00918 1/20 0.33
FAHD1 Q6P587 1/20 0.33
LMNA P02545 1/20 0.32
KDM4E B2RXH2 1/20 0.32
MAPT P10636 1/20 0.32
ALOX15 P16050 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glycolic Acid SCHEMBL11774353 1.00 CA4 (0.47) CA4OR51E2CASP1FFAR3HDAC3
Glycolic Acid SCHEMBL331529 0.96 CA4 (0.50) CA4OR51E2CASP1FFAR3HDAC3
Glycolic Acid SCHEMBL1940114 0.92 CA4 (0.47) CA4OR51E2CASP1FFAR3HDAC3
Glycolic Acid SCHEMBL9275875 0.92 CA4 (0.47) CA4OR51E2CASP1FFAR3HDAC3
Glycolic Acid SCHEMBL1940121 0.92 OR51E2 (0.50) CA4OR51E2CASP1FFAR3HDAC3
Glycolic Acid SCHEMBL1051586 0.92 CA4 (0.47) CA4OR51E2CASP1FFAR3HDAC3
Glycolic Acid SCHEMBL1940122 0.92
Glycolic Acid SCHEMBL1940116 0.92
Glycolic Acid SCHEMBL9053011 0.92
Glycolic Acid SCHEMBL224370 0.92

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 379 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10865525-B2 Biopolymer sizing agents SOLENIS TECHNOLOGIES, L.P. (US) 2020-12-15 US claimed
US-10865526-B2 Method for improving the resistance of paper and paperboard to aqueous penetrants SOLENIS TECHNOLOGIES, L.P. (US) 2020-12-15 US claimed
US-20190330803-A1 METHOD FOR IMPROVING THE RESISTANCE OF PAPER AND PAPERBOARD TO AQUEOUS PENETRANTS SOLENIS TECHNOLOGIES, L.P. (US) 2019-10-31 US claimed
EP-3452658-A1 BIOPOLYMER SIZING AGENTS Solenis Technologies, L.P. (CH) 2019-03-13 EP claimed
US-20170335520-A1 BIOPOLYMER SIZING AGENTS THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., AS NOTES COLLATERAL AGENT 2017-11-23 US claimed
US-9051475-B2 Rheology modified pretreatment compositions and associated methods of use PPG INDUSTRIES OHIO, INC. (US) 2015-06-09 US claimed
US-20140356617-A1 RHEOLOGY MODIFIED PRETREATMENT COMPOSITIONS AND ASSOCIATED METHODS OF USE PPG IND OHIO INC (US) 2014-12-04 US claimed
US-8852357-B2 Rheology modified pretreatment compositions and associated methods of use PPG INDUSTRIES OHIO, INC (US) 2014-10-07 US claimed
WO-2013052195-A2 RHEOLOGY MODIFIED PRETREATMENT COMPOSITIONS AND ASSOCIATED METHODS OF USE PPG INDUSTRIES OHIO, INC. (US) 2013-04-11 WO claimed
US-20130084466-A1 RHEOLOGY MODIFIED PRETREATMENT COMPOSITIONS AND ASSOCIATED METHODS OF USE PPG INDUSTRIES OHIO, INC. (US) 2013-04-04 US claimed
WO-1996009345-A1 USE OF ZIRCONIUM SALTS TO IMPROVE THE SURFACE SIZING EFFICIENCY IN PAPER MAKING HOPTON TECHNOLOGIES, INC. (US) 1996-03-28 WO claimed
US-5472485-A Alkenyl succinic anhydrides and/or ketene dimers crosslinked with a zirconium, hafnium or titanium salt HOPTON TECHNOLOGIES, INC. (US) 1995-12-05 US claimed
US-5460645-A Blend of hydroxylated polymer, carboxylated polymer, group four compound and water AKZO NOBEL N.V. (NL) 1995-10-24 US claimed
EP-0324382-A2 Zirconium (III) salts as cure co-catalysts for nonwoven binders comprising acrylamidoglycolic acid AIR PRODUCTS AND CHEMICALS, INC. (US) 1989-07-19 EP claimed
US-4844970-A CROSSLINKABLE ANIONIC POLYMER AIR PRODUCTS AND CHEMICALS, INC. (US) 1989-07-04 US claimed
US-12624224-B2 Systems for treating a metal substrate PPG INDUSTRIES OHIO, INC. (US) 2026-05-12 US disclosed
US-20260124642-A1 SYSTEMS AND METHODS FOR TREATING A SUBSTRATE PPG INDUSTRIES OHIO, INC. (US) 2026-05-07 US disclosed
EP-0324382-A2 Zirconium (III) salts as cure co-catalysts for nonwoven binders comprising acrylamidoglycolic acid AIR PRODUCTS AND CHEMICALS, INC. (US) 1989-07-19 EP disclosed
US-4844970-A CROSSLINKABLE ANIONIC POLYMER AIR PRODUCTS AND CHEMICALS, INC. (US) 1989-07-04 US disclosed
US-3966502-A Zirconium rinse for phosphate coated metal surfaces AMCHEM PRODUCTS, INC. (US) 1976-06-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260124642-A1 SYSTEMS AND METHODS FOR TREATING A SUBSTRATE PLA2G12B, PLA2G2D, SOD1 CA4 161/4885OR51E2 4328/4885CASP1 619/4885
US-12624224-B2 Systems for treating a metal substrate CHRM1, DNMT3B, ITGA4 CA4 812/4885OR51E2 4225/4885CASP1 2139/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.